Aromatic retinoid in the chemoprevention of the progression of nevoid basal-cell carcinoma syndrome.

Abstract

The management of nevoid basal-cell carcinomas in this syndrome is sometimes very difficult, because of the high number of tumors and of their particular localizations. The authors reviewed the literature and here report their experience in the treatment of nevoid basal-cell carcinoma syndrome with aromatic retinoid etretinate (RO 10-9359; Tigason).

• Authors: M Cristofolini, G Zumiani, P Scappini, F Piscioli
• Journal: The Journal of dermatologic surgery and oncology (J Dermatol Surg Oncol) Vol. 10 Issue 10 Pg. 778-81 (Oct 1984) ISSN: 0148-0812 [Print] United States
• PMID: 6491017 (Publication Type: Case Reports, Journal Article)

Topics

• Basal Cell Nevus Syndrome (drug therapy)
• Carcinoma, Basal Cell (drug therapy)
• Facial Neoplasms (drug therapy)
• Female
• Humans
• Middle Aged
• Neoplasm Recurrence, Local (prevention & control)